Cita APA

J.L., M., J., M., L.A., F., G., B., J., M. M., M., Q., . . . P., C. (2023). Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study.

Citación estilo Chicago

J.L., Manzano, et al. Adjuvant Dabrafenib and Trametinib for Patients With Resected BRAF -mutated Melanoma: DESCRIBE-AD Real-world Retrospective Observational Study. 2023.

Cita MLA

J.L., Manzano, et al. Adjuvant Dabrafenib and Trametinib for Patients With Resected BRAF -mutated Melanoma: DESCRIBE-AD Real-world Retrospective Observational Study. 2023.